Clinical trials
Coronary Arterial Disease (CAD) clinical trials
Below are recruiting coronary arterial disease (cad) clinical trials, each written for real people, not researchers. We’re tracking 189 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07269366Recruiting
Surgery vs stents for heart disease with weak heart pump
This trial compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stents (PCI)—in people whose heart pumps weakly (LVEF 40% or less). It aims to find which method works better for chest pain or recent heart issues.
GroningenAges 18 years+ - NCT07277686Recruiting
AI face scan for hidden heart disease in high-risk people
This trial tests whether an AI system can detect signs of coronary artery disease (blockages in heart arteries) by analyzing a photo of your face. It may help identify people in the community who need further heart testing.
Zhoukou, HenanAges 18 years+ - NCT07292909RecruitingPhase 4
Effect of Empagliflozin on Inflammation for Coronary Patients
This trial tests if the diabetes drug empagliflozin can help reduce inflammation in people with stable coronary artery disease who are planning to have a stent placed. It may offer a new way to protect heart health.
Beirut, BeirutAges 18 years+ - NCT07303439Recruiting
Comparing heart artery treatments in people with diabetes
This study compares using a special medicated balloon plus a medicated stent versus using just one of them to open blocked heart arteries in people with diabetes. It aims to find which treatment works better to keep arteries open longer.
Dublin, County DublinAges 18 years+ - NCT07316504Recruiting
Best method to fix a stent that is not fully open
This trial compares different ways to fix a stent that hasn't expanded properly inside a coronary artery. If you have a narrowed stent (restenosis) that looks like it's not fully open, this study may help determine the best treatment approach.
Clermont-Ferrand, AuvergneAges 18 years+ - NCT07318155RecruitingPhase 2
Study of SRSD107 for chronic heart or leg artery disease
This study tests a new medicine called SRSD107 for people with long-term blockages in heart or leg arteries. It aims to see if the drug can help prevent clots safely.
BeijingAges 18–75 - NCT07343804Recruiting
Dental root canal and heart disease risk study
This trial tests whether treating a tooth infection with a root canal can lower blood markers linked to heart risk in people with stable heart disease.
Rohtak, HaryanaAges 30 years+ - NCT07349875RecruitingPhase 4
Colchicine for non-severe coronary plaque: a trial
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
NanjingAges 18 years+ - NCT07354399Recruiting
Strength and cardio training for women with heart disease
This study looks at whether adding strength training to aerobic exercise helps women with coronary artery disease improve their fitness and build muscle. It may help you recover better after a heart event.
LjubljanaAges 18 years+ - NCT07368933Recruiting
A drug-coated balloon for heart artery blockages
This trial tests a balloon coated with two drugs to treat narrowed or re-narrowed arteries in the heart. It may help people with chest pain or recent mild heart attacks who need a procedure to open a blockage.
BarcelonaAges 18 years+ - NCT07380399Recruiting
Using the ulnar artery for heart tests when the radial artery is blocked
This trial looks at using the ulnar artery in the wrist instead of the radial artery for heart catheterization or stent placement, when the radial artery on that side is blocked. It may be an option for people who cannot use the other arm's radial artery.
AthensAges 18 years+ - NCT07386418Recruiting
Angina thresholds study for patients needing stent treatment
This trial is testing a new way to measure blood flow in the heart during exercise to better understand angina. You may be eligible if you have at least two blocked heart arteries and are scheduled for stent placement.
BasildonAges 18 years+ - NCT07401550Recruiting
Using a smartwatch to check heart health
This study uses a Fitbit smartwatch to track your heart activity and predict your risk for heart problems. You might help researchers learn how everyday wearable devices can spot early signs of heart disease.
Dublin, DublinAges 18 years+ - NCT07407816Recruiting
Supira heart support device for high-risk artery stenting
This trial tests a new device (the Supira system) that helps support your heart's pumping function during and after a high-risk procedure to open blocked coronary arteries. It is for people with heart failure and complex blockages who may need extra circulatory support.
Tbilisi, K'alak'i T'bilisiAges 18–90 - NCT07439133RecruitingPhase 3
Comparing new heart scan with standard tests for coronary disease
This trial is testing a new imaging agent called XTR004 to see if it can accurately find blockages in the heart's arteries. If you have suspected or confirmed stable coronary heart disease, this study may offer a less invasive way to diagnose your condition.
BeijingAges 18–80 - NCT07444697Recruiting
Erections after heart stent in men with and without heart attack
This study looks at how having a stent placed affects men's ability to have erections. It compares men who had a heart attack with those who had stable chest pain. If you take part, you will fill out short questionnaires about your sexual function and recovery for 6 months.
KirikkaleAges 30–75 - NCT07444931Recruiting
Predicting cardiac arrest risk in heart disease patients
This study looks at factors that may help predict sudden cardiac arrest in people with coronary artery disease. If you have a recent diagnosis of significant blockage or a heart attack, joining this trial could help improve risk assessment.
HaderaAges 18–75 - NCT07444957Recruiting
Safety of a drug-coated balloon for heart artery blockages
This study tests a special balloon coated with a drug called sirolimus to open blocked heart arteries. It may be an option for people with coronary artery disease who need a less invasive treatment.
Vigo, PontevedraAges 18 years+ - NCT07451522Recruiting
Comparing pain relief methods after heart bypass surgery
This study compares different ways to manage pain after coronary artery bypass grafting (CABG), which is heart bypass surgery. The goal is to find which approach works best and is safest for patients in the early recovery period.
Vladivostok, Outside USAges 18–75 - NCT07463664Recruiting
Drug-coated balloons for blocked heart arteries
This trial tests whether a drug-coated balloon, used without a permanent stent, can safely open completely blocked heart arteries that have been blocked for at least 3 months. It may offer an option that avoids leaving a metal stent behind.
Beijing, Beijing MunicipalityAges 18–80 - NCT07476040Recruiting
Better care for new stable chest pain
This trial tests a new way to manage stable chest pain that started recently. It aims to improve diagnosis and treatment for people suspected of having coronary artery disease.
AugsburgAges 30 years+ - NCT07476274Recruiting
Study of pneumonia after heart bypass surgery
This trial looks at pneumonia that happens in the hospital after coronary artery bypass surgery. It aims to understand who is at risk and how to better prevent or treat it.
Tomsk, Tomsk OblastAges 18 years+ - NCT07479056Recruiting
Fexuprazan to prevent stomach bleeding in heart patients on two blood thinners
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
Seoul, Eunpyeong-guAges 20 years+ - NCT07479433Recruiting
New approach to plan stent placement using CT scans
This study tests if using a special CT scan analysis can help doctors plan where to place stents for blocked arteries. It might make the procedure safer and more effective for people who are scheduled for a planned stent procedure.
Marietta, GeorgiaAges 18 years+
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for coronary arterial disease (cad)?
- Yes. Clin2 currently lists 189 recruiting coronary arterial disease (cad) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a coronary arterial disease (cad) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a coronary arterial disease (cad) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.